Stocks

The table gives an overview of all stocks, alphabetically sorted.
 AB INBEV ABI Apr 19, 2021 57.06 +0.51   
 Ackermans & van Haaren NV ACKB Apr 19, 2021 133.80 +0.30   
 Aedifica SA AED Apr 19, 2021 102.60 +1.28   
 Ageas AGS Apr 19, 2021 51.44 +0.67   
 APERAM APAM Apr 19, 2021 43.46 -0.96   
 Argen X SE ARGX Apr 19, 2021 230.20 -0.52   
 Barco NV BAR Apr 19, 2021 19.28 -0.87   
 Bel20 BEL20 Apr 19, 2021 3 996.90 +0.46   
 Cofinimmo COFB Apr 19, 2021 128.10 +0.71   
 Colruyt SA COLR Apr 19, 2021 49.85 +1.78   
 GALAPAGOS GLPG Apr 19, 2021 65.59 -0.23   
 Groupe Bruxelles Lambert SA GBLB Apr 19, 2021 92.32 +0.59   
 ING GROEP N.V. INGA Apr 19, 2021 10.51 -0.44   
 KBC Groep NV KBC Apr 19, 2021 63.28 +0.93   
 Proximus SADP PROX Apr 19, 2021 18.74 +1.02   
 Sofina SA SOF Apr 19, 2021 310.80 +0.91   
 Solvay SA SOLB Apr 19, 2021 104.85 -0.57   
 Telenet Group Holding NV TNET Apr 19, 2021 35.68 -0.50   
 UCB SA UCB Apr 19, 2021 83.08 +1.02   
 Umicore SA UMI Apr 19, 2021 47.75 +0.59   
 Warehousing & Distribution De Pauw WDP Apr 19, 2021 29.62 +0.75   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK